Overview

Price chart · mood · technical indicators

A

Agilent Technologies Incstock Healthcare

Diagnostics & Research

$129.8110.87%Current Market Mood:Neutral

Market Mood

Price Range (1Y)

$108.35$160.27

Current: $129.81

Idea: EMA

1Y Return

+15.7%

Sharpe 3Y

0.52

Market Comparison

vs Healthcare Sector & Diagnostics & Research Industry

+10.87%

1Y Performance

Healthcare

Sector 1Y

Diagnostics & Research

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio26.05Forward 22.37

EPS (TTM)$4.9860.0% YoY

Profit margin19.6%HEALTHCARE

Market cap$36.65BLarge cap

Wall Street coverage

$161.00median target· current $130.57 (+23.3%)18 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: 22.37
PEG ratio: 1.33
P/B: 5.37
P/S (TTM): 5.29
EV/EBITDA: 20.29

Profitability & growth

ROE (TTM): 21.3%
Operating margin: 23.7%
Revenue growth YoY: 10.0%
Dividend yield: 0.8%
Beta: 1.26

Last earnings

May 27, 2026 · Estimate $1.41 · Reported $1.49

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

46 articles · sorted by date

Page 1 of 3 · 46 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Agilent Technologies Inc

Company profile

Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.

Classification

Sector: Healthcare
Industry: Diagnostics & Research
Exchange: NYSE
Country: USA
Currency: USD

Company profile

HQ: 5301 STEVENS CREEK BOULEVARD, SANTA CLARA, CA
Fiscal year end: October
Latest quarter: Apr 30, 2026

Market cap$36.65B

Shares outstanding$282.4M

52W high$159.62

52W low$108.35

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer

Overview

A

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Agilent Technologies Inc Stock (US00846U1016): Valuation metrics under the microscope after recent e

Agilent Technologies Inc. Stock (US00846U1016): Piper Sandler Starts Coverage With Neutral Rating

Agilent Technologies Inc. Stock (US00846U1016): Piper Sandler Starts Coverage With Neutral Rating

Agilent Technologies Inc Stock (US00846U1016): earnings in focus after latest quarterly report

Agilent Technologies Inc. stock underperforms Thursday when compared to competitors

Piper Sandler initiates Agilent stock coverage with neutral rating By Investing.com

Piper Sandler initiates Agilent stock coverage with neutral rating

Agilent Technologies Inc. stock (US00846U1016): Life-science player updates investors after recent e

Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors

Agilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows

Is Agilent Technologies Stock Outperforming the Nasdaq?

Agilent Introduces the BioTek Cytation 9 Cell Imaging Multimode Reader

Agilent Technologies Inc. stock (US00846U1016): Solid Q2 earnings and cautious outlook keep investor

Is IQVIA Holdings Stock Outperforming the Dow?

Agilent Technologies Inc. stock (US00846U1016): Earnings rebound and life-science demand in focus

Agilent Technologies Inc. stock underperforms Monday when compared to competitors

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

Operating income of Agilent Technologies, Inc. – XETR:AG8

Agilent Technologies, Inc. Trade Ideas — XETR:AG8

Number of employees of Agilent Technologies, Inc. – XETR:AG8

About Agilent Technologies Inc

Classification

Company profile

A

Market Comparison

A Market Analysis

Overview

A

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Agilent Technologies Inc Stock (US00846U1016): Valuation metrics under the microscope after recent e

Agilent Technologies Inc. Stock (US00846U1016): Piper Sandler Starts Coverage With Neutral Rating

Agilent Technologies Inc. Stock (US00846U1016): Piper Sandler Starts Coverage With Neutral Rating

Agilent Technologies Inc Stock (US00846U1016): earnings in focus after latest quarterly report

Agilent Technologies Inc. stock underperforms Thursday when compared to competitors

Piper Sandler initiates Agilent stock coverage with neutral rating By Investing.com

Piper Sandler initiates Agilent stock coverage with neutral rating

Agilent Technologies Inc. stock (US00846U1016): Life-science player updates investors after recent e

Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors

Agilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows

Is Agilent Technologies Stock Outperforming the Nasdaq?

Agilent Introduces the BioTek Cytation 9 Cell Imaging Multimode Reader

Agilent Technologies Inc. stock (US00846U1016): Solid Q2 earnings and cautious outlook keep investor

Is IQVIA Holdings Stock Outperforming the Dow?

Agilent Technologies Inc. stock (US00846U1016): Earnings rebound and life-science demand in focus

Agilent Technologies Inc. stock underperforms Monday when compared to competitors

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

Operating income of Agilent Technologies, Inc. – XETR:AG8

Agilent Technologies, Inc. Trade Ideas — XETR:AG8

Number of employees of Agilent Technologies, Inc. – XETR:AG8

About Agilent Technologies Inc

Classification

Company profile

A

Market Comparison